Dr. Ulrich Storz

Ulrich Storz received his doctorate from the University of Münster in 2002 with a thesis in the field of neurobiology.

He then completed his training as a German Patent Attorney. In 2006, he was admitted as a representative before the European Patent Office.

Dr. Storz's main areas of practice are the prosecution and enforcement of patent applications and patents as well as the preparation of freedom-to-operate analyses and expert opinions. He also advises on patent strategy issues, in particular in the life sciences sector (biotechnology, biophysics, biochemistry and microbiology), especially in the field of therapeutic antibodies.

Ulrich Storz is regularly involved in major antibody opposition proceedings before the European Patent Office. He also has extensive experience in gene editing technologies including CRISPR, TALEN and ZFN, and also works in the fields of CAR-T cells, stem cell technologies, plant biotechnology and enzymes.

In addition, in recent years he has supported a large number of extensive due diligence projects in the pharmaceutical/life sciences sector with volumes of between 500,000 and 100 million euros.

Dr. Storz organises the annual "Rheinische Biopatent-Forum" and regularly publishes in the journal "mAbs" on patent issues relating to therapeutic antibodies.

Ulrich Storz was born in Münster in 1969 and now lives with his family in the Rhineland, halfway between Cologne and Düsseldorf. In addition to German, he speaks fluent English and French. His hobbies include mountain biking and sailing, and he occasionally picks up a guitar.

Juve_Magazine
"Michalski Hüttermann (...) are one of the best-known patent attorneys for biotech patents in Germany"

IAM1000
"Cases concerning therapeutic antibodies at the EPO are likely to carry Ulrich Storz's name."

IP STARS
Represented among the IP Stars in the MIP Handbook.